Endocrine Research

This article clarifies the critical pharmacological differences between SERMs (Enclomiphene, Clomiphene, Tamoxifen) and thyroid hormones (T3, T4), two commonly confused families of hormone-modulating compounds. Many users mistakenly treat them as interchangeable “hormone optimizers” for stacking or substitution, which carries unnecessary physiological risks. This breakdown compares their molecular structures, receptor targets, and core regulatory pathways: SERMs act on estrogen receptors to modulate the HPG axis and endogenous testosterone output, while T3/T4 bind universal nuclear thyroid receptors to control basal metabolism, thermogenesis, and systemic cellular function. It further distinguishes Clomiphene’s dual-isomer composition from purified Enclomiphene, alongside Tamoxifen’s unique tissue-selective activity. This evidence-based guide eliminates common endocrine misconceptions and defines safe, research-only application boundaries for laboratory reference.